Substance / Medication

Paroxetine hydrochloride

Overview

Active Ingredient
paroxetine
RxNorm CUI
32937

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

45 trials linked to this intervention

45
Total Trials
4
Recruiting
12
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Psychotherapeutic Interventions Used in Psychological Treatment Studies With Syrian Refugees: A Systematic Review.
Yılmaz Tuğba, Karakuş Cansu · Trauma Violence Abuse · 2026
PMID: 39718007Meta-Analysis
Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis.
Archer Charlotte, Wiles Nicola, Kessler David et al. · J Affect Disord · 2025
PMID: 39271062Meta-Analysis
Panic disorder during pregnancy and the first three years after delivery: a systematic review.
Verhees F Gerrik, Bendau Antonia, Unger Stefanie et al. · BMC Pregnancy Childbirth · 2025
PMID: 39825251Meta-AnalysisFull text (PMC)
Schizophrenia spectrum disorders with comorbid panic: A systematic review.
Veras André Barciela, Ribeiro Karyson Macruz, Peixoto Clayton et al. · Schizophr Res · 2025
PMID: 40010006Meta-Analysis
Panic Disorder in Patients With Vestibular Dysfunction: A Systematic Review and Meta-analysis.
McCray Lauren R, Kim Cory H, Nguyen Shaun A et al. · Otol Neurotol · 2025
PMID: 40210233Meta-Analysis
Neurochemical and genetic factors in panic disorder: a systematic review.
Moraes Adriana Carvalho Natal, Wijaya Clarissa, Freire Rafael et al. · Transl Psychiatry · 2024
PMID: 39025836Meta-AnalysisFull text (PMC)
Association between 5-HT1A receptor C-1019G, 5-HTTLPR polymorphisms and panic disorder: a meta-analysis.
Zhu Wenli, Bu Yangying, Wu Lijuan et al. · Aging (Albany NY) · 2024
PMID: 39207450Meta-AnalysisFull text (PMC)
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
Roscoe Joseph A, Morrow Gary R, Hickok Jane T et al. · Breast Cancer Res Treat · 2005
PMID: 15754122Trial
Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.
Holroyd Kenneth A, Labus Jennifer S, O'Donnell Francis J et al. · Headache · 2003
PMID: 14511278TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Paroxetine hydrochloride (substance)
SNOMED CT
96214003
UMLS CUI
C0771019
RxNorm CUI
32937

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

5
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
45
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.